Latest Breaking News On - Cancer infusion services - Page 1 : comparemela.com

New Union Medical Center on track for March 2025 opening | Spartanburg News

New Union Medical Center on track for March 2025 opening | Spartanburg News
postandcourier.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from postandcourier.com Daily Mail and Mail on Sunday newspapers.

Paul newhouseDolly partonGibbs cancer infusion servicesUnion medical centerCherokee coBearden josey centerSpartanburg regional foundationCity of unionUnion industrial parkBreast health mammography servicesSpartanburg coUnion industrialWallace thomson hospitalSpartanburg regional healthcare systemCancer infusion servicesWestgate mall

Truqap/Faslodex Delays Time to Breast Cancer Progression, Next Therapy

Adding Truqap to Faslodex improved outcomes in patients with locally advanced or metastatic HR-positive, HER2-negative breast cancer.

United statesSan franciscoTruqap faslodexUniversity of californiaDrug administrationBreast cancer congressDepartment of medicineCancer infusion servicesHelen diller comprehensive cancer centerBreast oncologyClinical trials educationHelen diller comprehensive cancer

Capivasertib/Fulvestrant Improves PFS2 in Pretreated PIK3CA/AKT1/PTEN+ HR+/HER2– Breast Cancer

Capivasertib plus fulvestrant improved time to second progression in patients with pretreated HR-positive, HER2-negative advanced breast cancer.

San franciscoUnited statesDepartment of medicineHelen diller comprehensive cancer centerCancer infusion servicesUniversity of californiaBreast cancer congressBreast oncologyClinical trials educationHelen diller comprehensive cancerCancer congress

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology

Drs Graff, Mahtani, McCann, and Rugo share moments that sparked their interest in oncology and setbacks they overcame when building their careers.

Rhode islandUnited statesBrown universityUniversity of california san franciscoAshling wahnerStephaniel graffKellye mccannReshmal mahtaniUniversity of californiaMiami cancer instituteCancer infusion servicesBreast oncology at lifespan cancer instituteDivision of hematologyHelen diller family comprehensive cancer centerBreast medical oncology at baptist health wellnessLive on air

Toxicity Profile With Trastuzumab Deruxtecan Proves Consistent, Manageable in HER2-Low Metastatic Breast Cancer

Treatment with trastuzumab deruxtecan resulted in lower exposure-adjusted incidence rates per patient-year of treatment-emergent adverse effects compared with treatment of physician’s choice in patients with HER2-low unresectable and/or metastatic breast cancer, according to safety analysis from the phase 3 DESTINY-Breast04 trial.

United statesSan franciscoPionyr immunotherapeuticsDaiichi sankyoTaiho oncology incCancer infusion servicesBreast cancer annual congressNovartis pharmaceuticals corporationDaiichi sankyo incSermonix pharmaceuticals incHelen diller family comprehensive cancer centerVeru incRoche ag genentech incDepartment of medicineAstellas pharma incMerck co inc